Activity Provided By:

CheckRare

Assessing, Monitoring, and Managing Respiratory Involvement in Lysosomal Disorders

Overview / Abstract:	Ozlem Gore-Alpan, MD of LDRTC and John Bach, MD, Professor of Neurology at Rutgers School of Medicine discuss best practices to manage respiratory complications in persons with lysosomal disorders. At the end of this activity, participants should be able to: - Describe the most common LSDs that have pulmonary complications. - Describe best practices to manage pulmonary symptoms in Pompe disease. - Describe best practices to manage pulmonary symptoms in MPSs. - Describe best practices to manage sleep apnea in lysosomal diseases.
Expiration	Dec 19, 2024
Credits / Hours	1.0
Accreditation	American Academy of CME
Presenters / Authors / Faculty	Ozlem Goker-Alpan, MD Founder and President, Lysosomal & Rare Disorders Research & Treatment Center (LDRTC). John Bach, MD Professor of Physical Medicine and Rehabilitation, Professor of Neurology, Rutgers New Jersey Medical Center.
Sponsors / Supporters / Grant Providers	Takeda, Sanofi, Amicus Therapeutics and Chiesi USA
Keywords / Search Terms	CheckRare rare disease, LSDs, pulmonary complications, pulmonary, Pompe disease, Gaucher, MPS, Fabry, sleep apnea in lysosomal diseases Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map